Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-10-10
|
pubmed:abstractText |
Besides the role of histamine (HA) as a neurotransmitter, a new concept has emerged presenting HA as an immunomodulator. Several studies have demonstrated interactions among HA, interleukin-1 beta (IL-1 beta) and tumor necrosis factor (TNF), suggesting a possible bidirectional communication among them. In this study we have investigated the effects of i.p. administrations of HA diphosphate (6 mumol/kg) and alpha-fluoromethylhistidine (FMH; 100 mg/kg) on TNF-alpha levels in the hippocampus, hypothalamus, and posterior hypothalamic region of the rat brain. The concentrations of TNF-alpha at 0 (Control, C) and 30 min after i.p. administration of HA were 0.26 +/- 0.02 pg/mg and 0.32 +/- 0.02 pg/mg in the hippocampus, 0.46 +/- 0.04 pg/mg and 0.09 +/- 0.006 pg/mg (p < 0.01) in the hypothalamus, and 0.47 +/- 0.05 pg/mg and 0.26 +/- 0.05 pg/mg in the posterior hypothalamic region. Three hours after FMH administration, an increase in the hippocampal levels of TNF-alpha was observed (0.43 +/- 0.04 pg/mg; p < 0.01), while in the hypothalamus (0.11 +/- 0.02 pg/mg; p < 0.01) and in the posterior hypothalamic region (0.21 +/- 0.04 pg/mg; p < 0.05) a decrease in TNF-alpha levels was detected. These results suggest that changes in the histaminergic system influence TNF-alpha production in the brain in an area-specific fashion.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Histamine,
http://linkedlifedata.com/resource/pubmed/chemical/Histidine Decarboxylase,
http://linkedlifedata.com/resource/pubmed/chemical/Methylhistidines,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-fluoromethylhistidine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1023-3830
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
55-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7664030-Animals,
pubmed-meshheading:7664030-Brain Chemistry,
pubmed-meshheading:7664030-Female,
pubmed-meshheading:7664030-Hippocampus,
pubmed-meshheading:7664030-Histamine,
pubmed-meshheading:7664030-Histidine Decarboxylase,
pubmed-meshheading:7664030-Hypothalamus,
pubmed-meshheading:7664030-Methylhistidines,
pubmed-meshheading:7664030-Rats,
pubmed-meshheading:7664030-Rats, Sprague-Dawley,
pubmed-meshheading:7664030-Tumor Necrosis Factor-alpha
|
pubmed:year |
1995
|
pubmed:articleTitle |
Effects of histamine and alpha-fluoromethylhistidine on brain tumor necrosis factor levels in rats.
|
pubmed:affiliation |
Department of Biomedical Research, Basic and Clinical Research Center, La Coruña, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|